Xarelto Bleeding Lawsuit Gets Rolling In Louisiana

Everyone’s seen the commercials urging patients who have taken Xarelto to contact the law firms’ numbers onscreen immediately to join a xarelto bleeding lawsuit. Well, the drug companies are actually countering the wrongful death lawsuits and complaints contending that a third party is supporting the nationwide lawsuits as a witch hunt.

In addition, Bayer and Johnson & Johnson contend that doctors have not prescribed other drugs (namely 50-year-standing and trusted blood thinner Warfarin in its place.)

The first xarelto bleeding lawsuit began in April in New Orleans. This patient experienced severe gastrointestinal bleeding within the first month of taking Xarelto. It landed him in the hospital. There’s no antidote, and doctors had to do a costly and dangerous blood transfusions. He could have bled to death.

This claimant calls out manufacturer negligence because they did not inform doctors or patients that there is no antidote to the drug; meaning its blood thinning properties cannot be reversed once it gets to work. He was fortunate to survive, because his doctors were able to counter Xarelto with a blood transfusion in time.

Hundreds of the 10,000 other Xarelto wrongful death lawsuits time was not on their side. Many of those patients died from exactly that bleeding issue.

The Pharmaceutical Companies Respond

In response, the drug companies came back swinging with responses that seem weak. They claim Xarelto is more effective than Warfarin and is safe. Warfarin has been trusted as the main blood thinner for at least 50 years. In theory should not Warfarin also cause bleeding deaths because it too is a blood thinner?

Actually, Warfarin can cause bleeding out episodes that lead to death, if it is improperly dosed. There’s no money in suing about a long-standing blood thinner, though. If patients take too much Warfarin, they can bleed to death. Though, hospitals use Warfarin all the time without much in the way of dramatic effect other than achieving blood thinning.

The patients could file malpractice lawsuits against doctors. Yet, the question begs, why are the pharmaceutical companies only citing that the doctors did not choose to prescribe something else? Judge Fallon dismissed this argument, and the lawsuits are collectively filed under MDL 2592.

The pharma companies are also counter-claiming that a third-party is funding the xarelto bleeding lawsuit in encouraging people to join the suit. FDA is still backing its approval of Xarelto, but has issued a black box warning for the drug. Black box warnings have been issued on other blood-related pharma products over the years.